Ascendis Pharma A/S (ASND) Institutional Ownership & Insider Trading
301 institutions reported holding Ascendis Pharma A/S shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 12 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ASNDAscendis Pharma A/SFollow ASND — free
—
Price chart with a free account
- Market cap
- 15.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters301 institutions held —% of the shares. Across filers that reported both quarters, shares held changed —.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 301 | 66 | — | — | — | — | — |
| Mar 26 | 8 | 8 | — | 0 | 8 | 0 | 0 |
Ascendis Pharma A/S — questions
- Who owns Ascendis Pharma A/S stock?
- 301 institutions reported Ascendis Pharma A/S shares in 13F filings for the quarter ended 2026-06-30. The largest: RA CAPITAL MANAGEMENT, L.P. (16.6%), T. Rowe Price Investment Management, Inc. (10.9%), Avoro Capital Advisors LLC (8.3%).
- Are Ascendis Pharma A/S insiders buying or selling?
- 12 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Ascendis Pharma A/S's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.